0001562180-20-002618.txt : 20200318
0001562180-20-002618.hdr.sgml : 20200318
20200318165637
ACCESSION NUMBER: 0001562180-20-002618
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200316
FILED AS OF DATE: 20200318
DATE AS OF CHANGE: 20200318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RECUPERO ANTHONY J
CENTRAL INDEX KEY: 0001210230
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38701
FILM NUMBER: 20725293
MAIL ADDRESS:
STREET 1: C/O SI-BONE, INC.
STREET 2: 471 EL CAMINO REAL, SUITE 101
CITY: SANTA CLARA
STATE: CA
ZIP: 95050
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SI-BONE, Inc.
CENTRAL INDEX KEY: 0001459839
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 262216351
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 471 EL CAMINO REAL, SUITE 101
CITY: SANTA CLARA
STATE: CA
ZIP: 95050
BUSINESS PHONE: 4082070700
MAIL ADDRESS:
STREET 1: 471 EL CAMINO REAL, SUITE 101
CITY: SANTA CLARA
STATE: CA
ZIP: 95050
FORMER COMPANY:
FORMER CONFORMED NAME: SI-Bone Inc.
DATE OF NAME CHANGE: 20090326
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-03-16
false
0001459839
SI-BONE, Inc.
SIBN
0001210230
RECUPERO ANTHONY J
C/O SI-BONE, INC.
471 EL CAMINO REAL, SUITE 101
SANTA CLARA
CA
95050
false
true
false
false
Chief Commercial Officer
Common Stock
2020-03-16
4
M
false
3000.00
4.32
A
75464.00
D
Common Stock
2020-03-16
4
S
false
1156.00
11.0575
D
74308.00
D
Common Stock
2020-03-16
4
S
false
1723.00
11.6094
D
72585.00
D
Common Stock
2020-03-16
4
S
false
21.00
12.37
D
72564.00
D
Common Stock
2020-03-16
4
S
false
100.00
13.97
D
72464.00
D
Stock Option (Right to Buy)
4.32
2020-03-16
4
M
false
3000.00
0.00
D
2026-07-26
Common Stock
3000.00
108190.00
D
The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $10.28 to $11.24, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $11.33 to $12.08, inclusive.
Includes 68,825 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.
The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.
/s/ Michael A. Pisetsky, Attorney-in-Fact for Anthony J. Recupero
2020-03-18